EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review

Marta Salek iD, Allison Silverstein, Alyssa Tilly, Pascale Yola Gassant, Sanjeeva Gunasekera iD, Diriba Fufa Hordofa, Donna Hesson, Caitlyn Duffy, Nauman Malik iD, Michael McNeil iD, Lisa M Force, Nickhill Bhakta und 2 weitere

Cancer Medicine · 2023-09 · 12 (17) · 18133-18152

DOI: 10.1002/cam4.6375 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Cancer Medicine, online erschienen am 01.08.2023. Verfasst von Marta Salek und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Developing Countries, Breast Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

In this scoping review, we evaluated existing literature related to factors influencing treatment decision‐making for patients diagnosed with cancer in low‐ and middle‐income countries, noting factors that influence decisions to pursue treatment with curative versus non‐curative intent. We identified an existing framework for adult cancer developed in a high‐income country (HIC) context and described similar and novel factors relevant to low‐and middle‐income country settings.

Methods

We used scoping review methodology to identify and synthesize existing literature on factors influencing decision‐making for pediatric and adult cancer in these settings. Articles were identified through an advanced Boolean search across six databases, inclusive of all article types from inception through July 2022.

Results

Seventy‐nine articles were identified from 22 countries across six regions, primarily reporting the experiences of lower‐middle and upper‐middle‐income countries. Included articles largely represented original research (54%), adult cancer populations (61%), and studied patients as the targeted population (51%). More than a quarter of articles focused exclusively on breast cancer (28%). Approximately 30% described factors that influenced decisions to choose between therapies with curative versus non‐curative intent. Of 56 reported factors, 22 novel factors were identified. Socioeconomic status, reimbursement policies/cost of treatment, and treatment and supportive care were the most commonly described factors.

Conclusions

This scoping review expanded upon previously described factors that influence cancer treatment decision‐making in HICs, broadening knowledge to include perspectives of low‐ and middle‐income countries. While global commonalities exist, certain variables influence treatment choices differently or uniquely in different settings. Treatment regimens should further be tailored to local environments with consideration of contextual factors and accessible resources that often impact decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developing CountriesBreast NeoplasmsAdultHumansChildFemaleIncome

Stichwörter der Autor:innen

decision-makinglow- and middle-income countriesoncologypediatric oncologyscoping review

Autor:innen und Institutionen

  • Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Division of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Oncology, Saint-Damien Hospital, Port-au-Prince, Haiti.
  • Department of Paediatric Oncology, National Cancer Institute, Maharagama, Sri Lanka.
  • Department of Pediatrics and Child Health, Jimma University Medical Center, Jimma, Ethiopia.

ORCID-Profile: Marta Salek, Sanjeeva Gunasekera, Nauman Malik, Michael McNeil, Erica C Kaye

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Salek, M., Silverstein, A., Tilly, A., Gassant, P. Y., Gunasekera, S., Hordofa, D. F., Hesson, D., Duffy, C., Malik, N., McNeil, M., Force, L. M., Bhakta, N., Rodin, D., & Kaye, E. C. (2023). Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review. Cancer Medicine, 12(17), 18133-18152. https://doi.org/10.1002/cam4.6375

Vancouver

Salek M, Silverstein A, Tilly A, Gassant PY, Gunasekera S, Hordofa DF, et al. Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review. Cancer Medicine. 2023;12(17):18133-18152. doi:10.1002/cam4.6375

BibTeX
@article{Salek2023,
  author = {Salek, Marta and Silverstein, Allison and Tilly, Alyssa and Gassant, Pascale Yola and Gunasekera, Sanjeeva and Hordofa, Diriba Fufa and Hesson, Donna and Duffy, Caitlyn and Malik, Nauman and McNeil, Michael and Force, Lisa M and Bhakta, Nickhill and Rodin, Danielle and Kaye, Erica C},
  title = {Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {17},
  pages = {18133--18152},
  doi = {10.1002/cam4.6375}
}
Kostenlos starten →